EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex:AIS) announced that it has received, along with its partner Jazz Pharmaceuticals Inc., the BioBusiness Network “2007 Innovative Biotech/Biotech Deal of the Year” award for innovation in deal making. Antares and Jazz Pharmaceuticals signed a worldwide product development and license agreement this past July. The product candidate underlying this agreement is being developed to treat a significant CNS disorder and is based on Antares’ proprietary ATD™ (Advanced Transdermal Delivery) gel system. Jazz Pharmaceuticals will pay Antares upfront and product development milestones in addition to payments for any future development activities as well as royalties on future product sales. Under the agreement Jazz Pharmaceuticals is responsible for development and commercialization of this product candidate and will cover the costs of clinical trials, regulatory filings, and all manufacturing and marketing.
